| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1f0cae270c1ab98750dc8593e48a6129
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5161f961b768730987d5591474eb8d44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bc2b03342511abc88f60c63f2acd96d0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6c60473bfd7257d987aeb6b480611a0c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fa45225022a93501d121676079efd2fe |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-25
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-408
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2-0082 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-162
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L29-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L29-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N37-46 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-29
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-08 |
| filingDate |
2008-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2014-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c6a8c4baa928ff61eccfe08dfd29bd58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2db05861a7ca8326ffdcc40fb9fce424
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_15c26a2f50e81ff2d5b18cbf156072a3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_08ce83259881596926f4f9a4c49f0e3f |
| publicationDate |
2014-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-8728793-B2 |
| titleOfInvention |
Amphipathic alpha-helical peptide compositions as antiviral agents |
| abstract |
The invention features methods and compositions that exploit the ability of amphipathic alpha-helical (AH) peptides to cause disruption of lipid-containing vesicles, such as enveloped viruses, in a size-dependent manner. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021234452-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022152939-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10351604-B2 |
| priorityDate |
2007-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |